Please do not leave this page until complete. This can take a few moments.
The biomanufacturing park being built at the site of the former Worcester State Hospital will now be known as The Reactory, according to landowner Worcester Business Development Corp.
What level of digital risk are you willing to tolerate?
Marlborough insulin delivery company CeQur has named medtech veteran Bradley Paddock as its new CEO.
The Massachusetts Life Sciences Center is launching a new program for investments of up to $1 million go to promising life science startups in regions outside of the Boston biotech cluster.
Jon Weaver took over as president and CEO of Worcester biotech incubator Massachusetts Biomedical Initiatives after Kevin O’Sullivan retired at the end of 2018 after two decades leading the agency.
Boston may have lost out in the competition to lure Amazon's second headquarters to the city, but the Seattle-based tech giant plans to hire 2,000 employees to work in a new Seaport office tower beginning in 2021.
Marlborough cardiac device firm CardioFocus has completed a $55-million round of financing intended to accelerate the commercial introduction of a new generation of its flagship product.
The U.S. Food and Drug Administration has approved the first two tests to detect certain sexually transmitted infections outside of the genitals, and one of those tests belongs to Marlborough medical device maker Hologic.
A Worcester Polytechnic Institute researcher is working to find a way to determine which organisms found in the wild are genetically engineered, unlike their naturally existing cousins.
Hologic CEO Steve MacMillan was the fifth-highest-paid CEO among the country's largest public companies, according to the latest annual analysis by The Wall Street Journal.
Pepperell-based Masy BioServices, a biorepository company, is continuing its expansion on the eastern seaboard by opening an office in North Carolina's Research Triangle Park.
Worcester medical device contract manufacturer Cogmedix is expanding its facilities and moving into a new headquarters at an 80,000-square-foot building in West Boylston.
Marlborough medical device giant Boston Scientific will acquire a California biotech company specializing in treating lumbar spinal stenosis for at least $465 million.
Veruna, a Hopkinton company specializing in insurance technology software, has completed a $6-million funding round.
AbbVie, a Worcester pharmaceutical facility, has joined a statewide program aiming to help low-income students find opportunities in high-demand biotechnology firms.